These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 9462445

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
    Fitoussi F, Doit C, Benali K, Bonacorsi S, Geslin P, Bingen E.
    Antimicrob Agents Chemother; 1998 Apr; 42(4):942-4. PubMed ID: 9559815
    [Abstract] [Full Text] [Related]

  • 6. Molecular characteristics and susceptibility to antibiotics of serogroup A Neisseria meningitidis strains isolated in Senegal in 1999.
    Sow AI, Caugant DA, Cisse MF, Høiby EA, Samb A.
    Scand J Infect Dis; 2000 Apr; 32(2):185-7. PubMed ID: 10826906
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
    Pikis A, Donkersloot JA, Akram S, Keith JM, Campos JM, Rodriguez WJ.
    J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
    [Abstract] [Full Text] [Related]

  • 9. [Case report: difficulty in treating one event of Streptococcus pneumoniae meningitis].
    Hizel K, Güzel O, Altunçekiç A, Gür D, Arman D.
    Mikrobiyol Bul; 2003 Jan; 37(1):65-9. PubMed ID: 12838680
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN, Woo JH, Kim YS, Ryu J, Kim MN, Pai CH.
    Chemotherapy; 2000 Jan; 46(5):303-8. PubMed ID: 10965094
    [Abstract] [Full Text] [Related]

  • 13. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
    Gerber CM, Cottagnoud M, Neftel KA, Täuber MG, Cottagnoud P.
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis.
    Sicilia T, Estévez E, Rodríguez A.
    Chemotherapy; 1981 Dec; 27(6):405-13. PubMed ID: 6794992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative in-vitro activity of moxifloxacin, penicillin, ceftriaxone and ciprofloxacin against pneumococci isolated from meningitis.
    Tarasi A, Capone A, Tarasi D, Cassone M, Bianco G, Venditti M.
    J Antimicrob Chemother; 1999 Jun; 43(6):833-5. PubMed ID: 10404324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.